Vizient Announces Milestone in Fight to End Drug Shortages: 100 Million Additional Units of Essential Medications Through Novaplus Enhanced Supply Program in Under Two Years
Retrieved on:
Mardi, octobre 26, 2021
Medical Supplies, Health, Hospitals, Practice Management, General Health, Pharmaceutical, Hospital, Robert Kistner, Ethisphere Institute, Patient, Program, Solution, Health, COVID, Propofol, Medical device, Pharmaceutical industry, Renewable energy, Vizient, Inc., Vizient Novaplus and the Novaplus Enhanced Supply Program, VIZIENT, INC., VIZIENT NOVAPLUS AND THE NOVAPLUS ENHANCED SUPPLY PROGRAM
Vizient, Inc. today announced its Novaplus Enhanced Supply Program has brought 100 million additional units of inventory of essential medications to the supply chain, many used to treat life-threatening illnesses.
Key Points:
- Vizient, Inc. today announced its Novaplus Enhanced Supply Program has brought 100 million additional units of inventory of essential medications to the supply chain, many used to treat life-threatening illnesses.
- The Novaplus Enhanced Supply Program provides supply assurance for participating Vizient members through increased inventory commitment from suppliers and members for essential medications .
- Through Novaplus Enhanced Supply program, 676,000 additional units of the sedative had already entered the market at the time of the spike.
- Novaplus Enhanced Supply Program provides additional inventory of essential products through enhanced supplier partnerships to mitigate supply disruptions and demand surge.